サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1739337

デジタルゲノムの世界市場

Digital Genomes

出版日
ページ情報
英文 184 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.71円
デジタルゲノムの世界市場
出版日: 2025年06月03日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

デジタルゲノムの世界市場は2030年までに728億米ドルに達する見込み

2024年に337億米ドルと推定されるデジタルゲノムの世界市場は、2024年から2030年にかけてCAGR 13.7%で成長し、2030年には728億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるシーケンス＆アナライザー機器は、CAGR 16.1％を記録し、分析期間終了までに318億米ドルに達すると予測されます。DNA/RNA分析キット分野の成長率は、分析期間のCAGRで11.3％と推定されます。

米国市場は89億米ドルと推定、中国はCAGR 12.8％で成長予測

米国のデジタルゲノム市場は2024年に89億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに112億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは12.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ13.0％と11.5％と予測されています。欧州では、ドイツがCAGR約9.8%で成長すると予測されています。

世界のデジタルゲノム市場- 主要動向と促進要因まとめ

プレシジョンヘルスはデジタルゲノムの時代へ？

デジタルゲノム-個人の完全な遺伝コードを仮想的に表現し、高度なコンピューティングシステムを使用して保存・分析したもの-は、個別化医療、医薬品開発、疾病予防の状況を一変させつつあります。デジタルゲノムの世界市場は、次世代シーケンサー（NGS）、AIを活用したバイオインフォマティクス、クラウドベースのデータストレージの融合によって牽引されており、迅速でスケーラブルかつコスト効率の高い遺伝子解析が可能になっています。

決定的な動向は、サイロ化された遺伝子検査から統合デジタルゲノムプラットフォームへの移行であり、これは生のDNAデータ、表現型の連結、健康記録、リアルタイムのモニタリングを統一されたインターフェースに統合するものです。このようなプラットフォームは、腫瘍学、希少疾患診断、薬理ゲノミクス、集団ゲノミクスの取り組みにおいて利用が拡大しています。米国、英国、中国などの国々は、国家規模のゲノムマッピングプロジェクトに投資しており、データ量が豊富でクラウド上で安全なデジタルゲノムインフラストラクチャの採用を後押ししています。

技術的融合はゲノムの可能性をどのように解き放つのか？

AIと機械学習アルゴリズムはデジタルゲノム革命の中心的存在であり、迅速なバリアント検出、リスクモデリング、治療標的同定を促進しています。これらのテクノロジーは、臨床医が複雑なゲノムデータセットを解釈し、最適な治療とマッチングさせるのに役立っています。さらに、ウェアラブルに統合された健康データを介して、個人のゲノムプロファイルをリアルタイムで更新することが、特に縦断的な健康調査において可能になりつつあります。

ストレージと暗号化技術の進歩により、遺伝子データの安全な共有も実現可能になっています。GDPRに基づくEUやHIPAAに基づく米国のような規制環境における重要な懸念である患者のプライバシーを損なうことなく、ゲノムデータへの分散型アクセスを可能にするために、統合データモデルとブロックチェーンが検討されています。

需要が加速している市場とエンドユーザーは？

デジタルゲノム市場は北米と欧州で急拡大しており、アジア太平洋は政府が支援するゲノムシークエンシングプログラムとバイオテクノロジーエコシステムの拡大により、戦略的成長フロンティアとして浮上しています。エンドユーザーには、学術研究機関、病院、バイオ製薬会社、消費者直販（DTC）遺伝子検査プロバイダー、医療保険会社などが含まれます。

英国の100,000ゲノムプロジェクトやNIHのAll of Us研究プログラムのようなポピュレーションヘルス・イニシアチブが主要な成長触媒である一方、非公開遺伝子検査会社は消費者向けのゲノムダッシュボードを展開し、遺伝リスクとライフスタイルやウェルネスへの介入を結びつけています。

デジタルゲノム市場の成長の原動力は？

デジタルゲノム市場の成長は、ゲノム科学、AIアナリティクス、精密医療への需要の合流によってもたらされます。全ゲノムシーケンスの価格が上昇し、クラウドコンピューティングへのアクセスが容易になったことで、デジタルゲノムプラットフォームを採用する医療機関が増えています。

ヘルスケアシステムは、特に腫瘍学、心臓病学、神経学において、リスク層別化と早期介入におけるゲノミクスの価値を認識しつつあります。製薬会社はデジタルゲノムデータセットを利用して、新規薬剤ターゲットを特定し、遺伝子反応性に基づいて試験参加者を層別化しています。規制の明確化とデータ共有に関する世界な協力体制が、主流医療へのデジタルゲノムの統合をさらに促進しています。

セグメント

製品（シーケンス＆アナライザー機器、DNA/RNA分析キット、シーケンスチップ、シーケンス＆分析ソフトウェア、サンプル調製機器）、用途（臨床、法医学、創薬開発、その他の用途）、エンドユーザー（病院、診断センター＆法医学研究所、研究開発、その他のエンドユーザー）

調査対象企業の例（注目の44社）

  • 10x Genomics
  • Agilent Technologies, Inc.
  • ArcherDx, Inc.
  • BGI Genomics
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific SE
  • Fabric Genomics, Inc.
  • Foundation Medicine, Inc.
  • Genewiz
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • Myriad Genetics, Inc.
  • NanoString Technologies, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP33720

Global Digital Genomes Market to Reach US$72.8 Billion by 2030

The global market for Digital Genomes estimated at US$33.7 Billion in the year 2024, is expected to reach US$72.8 Billion by 2030, growing at a CAGR of 13.7% over the analysis period 2024-2030. Sequencing & Analyzer Instruments, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$31.8 Billion by the end of the analysis period. Growth in the DNA / RNA Analysis Kits segment is estimated at 11.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.9 Billion While China is Forecast to Grow at 12.8% CAGR

The Digital Genomes market in the U.S. is estimated at US$8.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.2 Billion by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.0% and 11.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.

Global Digital Genomes Market - Key Trends & Drivers Summarized

Is Precision Health Entering the Age of the Digital Genome?

Digital genomes-virtual representations of an individual’s complete genetic code stored and analyzed using advanced computing systems-are transforming the landscape of personalized medicine, drug development, and disease prevention. The global market for digital genomes is being driven by the convergence of next-generation sequencing (NGS), AI-enabled bioinformatics, and cloud-based data storage, enabling rapid, scalable, and cost-effective genetic analysis.

A defining trend is the shift from siloed genetic testing to integrated digital genome platforms, which consolidate raw DNA data, phenotype linkage, health records, and real-time monitoring into unified interfaces. These platforms are finding increasing use in oncology, rare disease diagnostics, pharmacogenomics, and population genomics initiatives. Countries such as the U.S., U.K., and China are investing in national-scale genome mapping projects, boosting the adoption of data-rich, cloud-secure digital genome infrastructure.

How Are Technological Convergences Unlocking Genomic Potential?

AI and machine learning algorithms are central to the digital genome revolution, facilitating rapid variant detection, risk modeling, and therapeutic target identification. These technologies are helping clinicians interpret complex genomic datasets and match them with optimal treatments-ushering in an era of predictive and preventive medicine. Moreover, real-time updates to individual genome profiles via wearable-integrated health data are becoming possible, especially in longitudinal health studies.

Advancements in storage and encryption technologies are also making secure sharing of genetic data feasible. Federated data models and blockchain are being explored to allow decentralized access to genomic data without compromising patient privacy, a key concern in regulated environments like the EU under GDPR or the U.S. under HIPAA.

Where Is Demand Accelerating and Who Are the End-Users?

The digital genome market is expanding rapidly in North America and Europe, with Asia-Pacific emerging as a strategic growth frontier due to government-backed genome sequencing programs and expanding biotech ecosystems. End-users include academic research institutions, hospitals, biopharmaceutical companies, direct-to-consumer (DTC) genetic testing providers, and health insurers.

Population health initiatives-such as the UK's 100,000 Genomes Project or the NIH's All of Us research program-are key growth catalysts, while private genetic testing companies are deploying consumer-facing genome dashboards to connect genetic risk with lifestyle and wellness interventions.

What’s Driving Growth in the Digital Genomes Market?

The growth in the digital genomes market is driven by a confluence of genomic science, AI analytics, and demand for precision medicine. Rising affordability of whole genome sequencing, along with increased accessibility to cloud computing, is enabling more institutions to adopt digital genome platforms.

Healthcare systems are recognizing the value of genomics in risk stratification and early intervention, particularly in oncology, cardiology, and neurology. Pharmaceutical firms are using digital genome datasets to identify novel drug targets and stratify trial participants based on genetic responsiveness. Regulatory clarity and global collaborations on data sharing are further fueling the integration of digital genomes into mainstream medicine.

SCOPE OF STUDY:

The report analyzes the Digital Genomes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software, Sample Preparation Instruments); Application (Clinical, Forensics, Drug Discovery & Development, Other Applications); End-User (Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • 10x Genomics
  • Agilent Technologies, Inc.
  • ArcherDx, Inc.
  • BGI Genomics
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific SE
  • Fabric Genomics, Inc.
  • Foundation Medicine, Inc.
  • Genewiz
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • Myriad Genetics, Inc.
  • NanoString Technologies, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Digital Genomes - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Genomic Sequencing Technologies Propel Demand for Digital Genome Platforms
    • Rising Use of AI in Genomic Data Interpretation Accelerates Clinical Application of Digital Genomes
    • Personalized Medicine Trends Strengthen Business Case for Genome Digitization
    • Integration of Genomic Data with EHR Systems Enhances Predictive Healthcare Models
    • Growing Demand for Population-Wide Genomic Screening Expands Digital Genome Infrastructure Investment
    • Increased Focus on Rare Disease Diagnosis Drives Adoption of Comprehensive Genomic Databases
    • Data Privacy Regulations in Genomics Create Both Challenges and Opportunities for Secure Platform Development
    • Collaborations Between Biotech Firms and Cloud Providers Spur Innovation in Scalable Genome Data Storage
    • Pharma R&D Shifts Toward Genotype-Driven Drug Discovery Highlights Need for Digital Genome Platforms
    • Public Health Genomics Programs in Asia and Europe Generate Long-Term Growth Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Digital Genomes Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Digital Genomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Digital Genomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Sequencing & Analyzer Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Sequencing & Analyzer Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for DNA / RNA Analysis Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for DNA / RNA Analysis Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sequencing Chips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Sequencing Chips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Sequencing & Analysis Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Sequencing & Analysis Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Sample Preparation Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Sample Preparation Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Diagnostic Centers & Forensic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Diagnostic Centers & Forensic Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • CHINA
    • Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 48: China Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 52: China Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Digital Genomes by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Digital Genomes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Europe 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 64: France Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: France 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 66: France Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: France 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 70: Germany Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Germany 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 72: Germany Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Germany 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 76: Italy Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Italy 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 78: Italy Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Italy 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 82: UK Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: UK 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 84: UK Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: UK 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of Europe 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of Europe 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Asia-Pacific 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 100: Rest of World Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Rest of World 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 102: Rest of World Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of World 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030

IV. COMPETITION